The higher risk of heart failure (HF) in African-American and Hispanic women compared with white women is related to the higher burden of risk factors (RFs) in minorities. However, it is unclear if there are differences in the association between the number of RFs for HF and the risk of development of HF and death within racial/ethnic groups.
H
eart failure (HF) is one of the leading causes of morbidity and mortality in older women and is expected to rise in prevalence by 25% over the next 2 decades because of an aging US population. [1] [2] [3] [4] Despite advances in therapy, HF continues to disproportionately affect African-American women compared with white women. 2, [5] [6] [7] In general, socioeconomic factors and predisposing risk factors (RFs) including hypertension and diabetes mellitus have been identified as important contributors to this excess risk. 2, 6, 8 Despite data on the incidence and prevalence of HF in women, which demonstrate higher risk of HF in African-American and Hispanic women, data examining the differential development of HF and subsequent risk of death in these groups are lacking. 2, 9 African-American and Hispanic women have higher prevalence of established RFs for HF, including atherosclerosis, hypertension, diabetes mellitus, obesity, and sedentary activity. 2, 3 The population attributable risk for HF based on individual RF has been widely described in whites, small populations of African-Americans, and to a lesser extent in Hispanics. 2, [10] [11] [12] In most studies, individual RFs have been associated with greater risk of developing HF in African-Americans and Hispanics. 2 Yet, the impact of these RFs may be much greater in African-American and Hispanic women who often have multiple RFs. 2 A strong target for reducing racial/ethnic disparities in HF may include identifying the risk of HF and death before and after developing HF, dependent on the number of RFs.
To address these questions, we examined HF development among African-American, white, and Hispanic women, using data from the WHI study (Women's Health Initiative), a large population-based study of postmenopausal women. Within each racial/ethnic group, we tested the hypothesis that compared with women with 0 baseline RF, women with subsequently higher number of baseline RFs would have increased risk of developing HF and dying before or after developing HF.
METHODS
The data, analytic methods, and study materials are available to other researchers for purposes of reproducing the results or replicating the procedure on request and approval of the WIH Publications and Presentations Committee.
Data Source
The WHI is a National Heart, Lung, and Blood Institutesupported study of US postmenopausal women followed for >20 years for evaluation of cardiovascular disease, cancer, and osteoporosis. 13 The original WHI population is one of the largest female-only population studies, including 161 808 diverse racial/ethnic women who were enrolled for either randomized clinical trials or an observational study. 14 The study includes self-reported medical information collected through interviews and surveys, anthropometric measurements by WHI personnel, and review of medical records for outcome determination.
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Study Cohort
A subcohort of the original WHI population was selected to study the epidemiology of HF in postmenopausal women. 5 This sample included 44 174 postmenopausal women who underwent annual assessment for HF adjudication from baseline enrollment (1993-1998) through 2010. Race and ethnicity were self-identified as non-Hispanic African American (African-American), Hispanic, and non-Hispanic White (white). This population included all participants who were randomized to the WHI hormone therapy trial (n=27 347) and an oversampling of minorities to include all nonhormone trial African-American (n=11 880) and Hispanic (n=4947) women. Adjudicated HF and death were as of data release of December 2014. Overlapping exclusions included participants of other races/ethnicities because of their small number of events (n=1042), self-report of HF or unknown HF at baseline (n=686), and participants with stroke attributed to atrial fibrillation because the covariates could not be separated (n=151). Participants with missing covariates (n=6768) were also excluded because the objective of this study was to assess risk based on number of RFs on study enrollment. Patients with missing covariates had no difference in incident HF or death than the final analysis sample (Table I in the Data Supplement). The final sample included 35 571 participants (Figure 1 ). The study was approved by the human subjects review committee at each WHI participating institution, and all participants provided written informed consent.
Outcomes of Interest
Participants were followed until development of the following outcomes: incident HF requiring hospitalization and all-cause mortality before or after developing HF. Data on incident HF was abstracted annually from medical records after self-report of hospitalizations. A trained committee adjudicated these hospitalizations as definite or probable HF based on symptoms, physical examination, clinical data, and therapy during a hospitalization, which has been described elsewhere. 3, 15 Allcause mortality was collected during routine WHI follow-up by family report and death certificate.
15
WHAT IS NEW?
• Across multiple racial/ethnic groups, the number of risk factors for heart failure (HF) is associated with risk of developing new-onset HF and death before HF.
• The number of risk factors for HF is not associated with risk of death after HF.
WHAT ARE THE CLINICAL IMPLICATIONS?
• Public efforts should target primary prevention of risk factors for HF, especially among African-Americans who have the highest rates of HF.
Explanatory Variables: RFs for HF
Established RFs for HF were defined per 2013 American College of Cardiology/American Heart Association Stage A classifications. 3 RFs for HF included having 1+ of the following risks in the absence of symptomatic HF: atherosclerosis (includes Stage B classifications of prior hospitalization for myocardial infarction because this is one of the largest etiologies of HF, prior percutaneous coronary intervention, prior coronary artery bypass graft surgery, history of carotid artery disease, stroke/transient ischemic attack, or peripheral vascular disease), diabetes mellitus (self-report of physician diagnosis and taking hypoglycemic medications), hypertension (self-report and taking antihypertensive medications, systolic blood pressure ≥140 mm Hg, or diastolic blood pressure ≥90 mm Hg by measurement on enrollment), obesity (body mass index ≥30 kg/m 2 by measurement on enrollment), and a recognized RFs for HF not included as Stage A: sedentary activity (<500 metabolic equivalent of task minute/week). 16 Metabolic syndrome was not included but can be inferred from the component RFs captured. Other established RFs for HF were excluded because they were unavailable in the WHI data set (cardiotoxin exposure and family history of cardiomyopathy). No baseline cardiac imaging was available for the population with RFs for HF.
Statistical Analysis
Baseline patient characteristics were compared between race and ethnicities, using χ 2 tests for categorical variables and analysis of variance for continuous variables. We consider 3 outcomes: (1) time to HF from baseline, (2) time to death before HF, and (3) time to death after HF. For (1), time to HF from baseline was defined as the number of days from enrollment to the first occurrence of HF. A participant was censored at last contact. Death was modeled as a competing risk for HF using Fine and Gray method, where subdistribution hazard was estimated. 17 For (2), time to death before HF was defined as the number of days from enrollment to death. Follow-up for death was censored at last contact, and we restrict participants to those who did not have incident HF during the follow-up. For (3), time to death after HF was defined as time from first incidence of HF to death, and participants were censored at last contact. Cox proportional hazard regression models were used for (2) and (3). Separate models were built for each outcome, and 3 sets of models were fitted: (1) menopausal hormone therapy control: where menopausal hormone therapy was adjusted given increased risk of cardiovascular disease with menopausal hormone therapy irrespective of race/ethnicity.
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; (2) age+menopausal hormone therapy: where age was added to the model (1); and (3) socioeconomic status+age+menopausal hormone therapy: where socioeconomic status (education, income, and insurance) was added to the model (2), given known racial/ethnic differences in HF presentation. 3 First, models were fitted for all the participants with race/ethnicity as a covariate to estimate subdistribution hazard ratios or hazard ratios and 95% confidence interval (CI) for the number of baseline RFs (1, 2, or 3+), with 0 RF as reference for the outcomes of interest. Then interactions between race/ ethnicity and number of baseline RFs were tested to determine whether risks varied by race/ethnicity. Finally, we built models within each race/ethnicity group to estimate subdistribution hazard ratios, hazard ratios, and 95% CI for the number of baseline RFs. Hispanic women were not assessed for all-cause mortality after HF because the event rate of incident HF was too low to yield precise estimates.
In the secondary analysis, associations between an individual RF and outcomes were performed using model (3), which is described above, and by adjusting for all other RFs. The same outcomes were chosen: HF, death before HF, and death after HF. Statistical analyses were performed using SAS 9.4 (Cary, NC), and the significance level was set at 0.05 for all tests.
RESULTS
Baseline Characteristics
During the enrollment period of 1993 to 1998, 35 571 women (34% African-American, 52% white, 14% The final study sample excluded participants with missing covariates and races/ethnicities that did not include African-American, white, and Hispanic women. HF indicates heart failure; TIA, transient ischemic attack; and WHI, Women's Health Initiative.
Hispanic) were followed for the development of HF (Table 1) . Racial/ethnic minority women were younger than white women (African-American mean age, 61.4; white, 64.0; Hispanic, 60.2; P<0.0001). The majority of patients had 1+ RFs at baseline across race and ethnicity, but AfricanAmericans had the most RFs at baseline. College education levels were higher among African-Americans (63.2%) and whites (61.9%) than Hispanics (46.9%). Approximately half of women from all race/ethnicities had an annual income of <$35 000, and >80% of women from all race/ethnicities had some form of health insurance.
Outcomes
Over an average 13 years of follow-up, 4.4% (n=524) African-American, 6.3% (n=1166) white women, and 1.8% (n=89) Hispanic women developed symptomatic HF requiring hospitalization. In the control which was adjusted for menopausal hormone therapy and fully adjusted models for age and socioeconomic status, having an additional RF was associated with a significantly higher risk of developing HF, compared with 0 RF ( Table II 
DISCUSSION
In one of the largest studies of a diverse racial and ethnic population of women, we found that an additional established RFs for HF was associated with significantly increased risk of HF and death prior to developing HF among African-American, Hispanic, and white women. Conversely, additional RFs for HF were not associated with increased risk of death after HF in either AfricanAmerican or white women.
Our study supports findings from smaller studies that address racial/ethnic differences in risk of HF based on the number of ideal RF. 11, 19 In the Jackson Heart Study of African-Americans (n=4195), a progressively reduced risk of incident HF was demonstrated with an increased number of Life's Simple 7 ideal RF, including ideal blood pressure, glucose, lipids, weight, daily exercise, balanced meals, and tobacco-free lifestyle. 11 Similarly, in the Multi-Ethnic Study of Atherosclerosis (n=6506), an increased number of ideal RF was associated with a trend toward reduced incidence of HF in African-Americans, whites, and Hispanics. 19 African-Americans and Hispanics demonstrated the greatest benefit with each additional ideal RFs. The decreased risk of death with more ideal RF has been demonstrated in a survey study that does not address racial/ethnic differences. 20 In the National Health and Nutrition Examination Survey (N=44 959), a higher number of Life's Simple 7 ideal RF was associated with reduced risk of all-cause death. 20 However, associations between the number of RF and risk of death after HF are less described in diverse racial/ethnic populations. Numerous studies have developed calculators to predict the risk of death after developing HF, but most assess risk based on specific types of RF, not the number of RF. 3 The WHI study is unique by demonstrating the risk of HF and death before or after HF based on the number of baseline RFs. Most studies have not addressed this combination of progressive events within the same population or within diverse racial/ethnic groups. Our study and the Life's Simple 7 literature suggest that preventing established RFs and pursuing ideal management of RFs may reduce racial/ethnic disparities in HF incidence and death prior to HF. 11, 19, 20 However, there is a noteworthy distinction. The lack of an association between the number of RF and risk of death after HF in African-Americans and whites implies that the preventative RF target should occur before HF develops. Additional study is warranted in a larger population of Hispanic women to determine if the same conclusion applies.
Multiple observational studies have demonstrated the obesity paradox in HF, as demonstrated in this study. 21, 22 Obesity was associated with increased risk of HF irrespective of race/ethnicity and increased risk of death before HF in Hispanics. However, obesity was protective for death after HF. Exercise is recommended in obese patients with HF because exercise is associated with improved exercise capacity and quality of life. 3, 23 The definitive trial has not been performed to determine if purposeful weight loss causes increased mortality among obese HF patients.
This study is subject to several limitations. First, RFs for HF did not include family history of cardiomy- Results are fully adjusted for menopausal hormone therapy, age, socioeconomic status, and other risk factors. All-cause mortality after HF was not applicable in Hispanics who had too few HF events to detect death after HF. CI indicates confidence interval; HF, heart failure; NA, not applicable; and RF, risk factor. *P value <0.05.
opathy and metabolic syndrome. However, metabolic syndrome should be represented with the capture of diabetes mellitus, hypertension, and obesity. Also, an interdependent relationship of the individual RF may influence HF outcomes. For this reason, we also assessed the risk of each outcome for each individual RF. Second, some of the patients may have structural heart disease without symptoms of HF because WHI participants had no imaging at baseline, and patients with prior myocardial infarction were not excluded. Systolic dysfunction at baseline was likely low given small rates of myocardial infarction at baseline, but the presence of left ventricular hypertrophy was likely missed given high baseline prevalence of hypertension. 24 Third, incident HF only included hospitalized events and may underreport development of symptomatic HF. However, the population that is hospitalized is at the highest risk for death 25 and thus a key group for study. Fourth, the socioeconomic status of participants demonstrate a nonrepresentative sample of the US racial/ ethnic minorities, but this is one of the largest population studies of diverse racial/ethnic women. Finally, the exact time of development of baseline RFs prior to WHI enrollment is not well captured for all RFs, and new development of some RFs during follow-up were not collected. However, the risk of long-term events after baseline provides important data that may inform public health targets.
CONCLUSIONS
Among the WHI population of postmenopausal women, compared with 0 RF, each additional RF was associated with an increased risk of HF and death before HF among African-American, Hispanic, and white women. However, additional RFs for HF were not associated with increased risk of death after HF diagnosis among either African-American or white women. Racial/ethnic disparities in HF may be reduced by seeking RF prevention. Further study of RF prevention interventions in longitudinal populations is warranted.
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